All lobbying filings
Agios Pharmaceuticals
Agios Pharmaceuticals filed a Q3 report for Agios Pharmaceuticals on October 17, 2025.
Lobbying for Agios Pharmaceuticals · Pharmacy, Medicare/Medicaid, Health Issues
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 17, 2025
Expenses
$10,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
Massachusetts
Government bodies contacted
2
Lobbying activity
3
Sickle Cell policy Biotech innovation
Biotech Innovation
Medicaid Reform